[ad_1]
In particular, those affected with a partial or total lack of the so-called “NKG2C receptor” became seriously ill, MedUni Vienna reported. “Therefore, this part of the immune response could also be an important target for drugs that could help prevent serious illness from Covid 19,” said virologist Elisabeth Puchhammer-Stckl.
“Lack of the receptor was particularly common in patients who had to be treated with Covid-19 in intensive care units, regardless of age or gender,” explained Puchhammer-Stckl.
